Operating Data

Aethlon Medical, Inc. (AEMD)

$ 5.3413
-0.1987 (-3.59%)
Year
A/P
2013
Actual
2014
Actual
2015
Actual
2016
Actual
2017
Actual
2018
Actual
2019
Actual
2020
Actual
2021
Projected
2022
Projected
2023
Projected
2024
Projected
2025
Projected
Revenue 1.231.620.760.890.390.150.230.650.760.881.021.191.38
Revenue (%)
EBITDA -3.56-3.03-3.96-4.35-6.07-4.80-5.97-5.90-9.21-10.72-12.47-14.50-16.87
EBITDA (%)
EBIT -3.58-3.06-3.99-4.38-6.10-4.83-6-5.93-9.27-10.78-12.54-14.59-16.97
EBIT (%)
Depreciation 0.010.020.040.040.030.040.030.030.060.070.080.090.11
Depreciation (%)




EBIT (Operating profit)(Operating income)(Operating earning) = GROSS MARGIN (REVENUE - COGS) - OPERATING EXPENSES (R&D, RENT)
EBIT = (1*) (2*) -> operating process (leverage -> interest -> EBT -> tax -> net Income)
EBITDA = GROSS MARGIN (REVENUE - COGS) - OPERATING EXPENSES (R&D, RENT) + Depreciation + amortization
EBITA = (1*) (2*) (3*) (4*) company's CURRENT operating profitability (i.e., how much profit it makes with its present assets and its operations on the products it produces and sells, as well as providing a proxy for cash flow) -> performance of a company
(1*) discounting the effects of interest payments from different forms of financing (by ignoring interest payments),
(2*) political jurisdictions (by ignoring tax), collections of assets (by ignoring depreciation of assets), and different takeover histories (by ignoring amortization often stemming from goodwill)
(3*) collections of assets (by ignoring depreciation of assets)
(4*) different takeover histories (by ignoring amortization often stemming from goodwill)